| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | U01AG084549 | Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD | 000 | 1 | NIH | 12/19/2024 | $0 |
| | 2025 | 2022 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 000 | 2 | NIH | 10/15/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $4,027,298 ) |
| | 2024 | 2024 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | U01AG084549 | Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD | 000 | 1 | NIH | 9/23/2024 | $1,594,649 |
| | 2024 | 2024 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R44AG085775 | Paving the Way to Phase 2 Trials of CMS121 for Alzheimer's Disease | 000 | 1 | NIH | 9/26/2024 | $2,432,649 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R44AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 7 | NIH | 7/28/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,800,610 ) |
| | 2022 | 2022 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 004 | 2 | NIH | 9/6/2022 | $243,187 |
| | 2022 | 2022 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 004 | 2 | NIH | 9/6/2022 | $2,095,627 |
| | 2022 | 2022 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 003 | 1 | NIH | 4/6/2022 | $251,666 |
| | 2022 | 2022 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 001 | 1 | NIH | 2/7/2022 | $210,130 |
| | 2022 | 2021 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 002 | 1 | NIH | 3/11/2022 | $0 |
| | 2022 | 2021 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 000 | 1 | NIH | 1/26/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,503,169 ) |
| | 2021 | 2021 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R01AG074447 | Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease | 000 | 1 | NIH | 9/8/2021 | $2,503,169 |
|
| Issue Date FY: 2020 ( Subtotal = $965,711 ) |
| | 2020 | 2020 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R44AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 7 | NIH | 5/29/2020 | $965,711 |
|
| Issue Date FY: 2019 ( Subtotal = $967,956 ) |
| | 2019 | 2019 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R44AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 6 | NIH | 6/25/2019 | $967,956 |
| | 2019 | 2017 | VIROGENICS, INC. | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1425 | SAN DIEGO | USA | R42AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 4 | NIH | 7/18/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $977,956 ) |
| | 2018 | 2018 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R44AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 001 | 5 | NIH | 8/15/2018 | $0 |
| | 2018 | 2018 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R44AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 5 | NIH | 7/17/2018 | $977,956 |
| | 2018 | 2017 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R42AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 4 | NIH | 7/11/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $728,550 ) |
| | 2017 | 2017 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R42AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 4 | NIH | 1/31/2017 | $728,550 |
| | 2017 | 2014 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R41AI104034 | Modulation of the Innate Immune System by Fisetin for the Treatment of AD | 000 | 2 | NIH | 1/23/2017 | $0 |
| | 2017 | 2014 | VIROGENICS | 4050 SORRENTO VALLEY BLVD STE O | SAN DIEGO | CA | 92121-1154 | SAN DIEGO | USA | R41AI104034 | Modulation of the Innate Immune System by Fisetin for the Treatment of AD | 001 | 2 | NIH | 1/30/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $771,449 ) |
| | 2016 | 2016 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R42AI104034 | Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD | 000 | 3 | NIH | 3/14/2016 | $771,449 |
|
| Issue Date FY: 2014 ( Subtotal = $599,968 ) |
| | 2014 | 2014 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R43AI100398 | siRNA Modulation of the Immune Response | 000 | 2 | NIH | 12/21/2013 | $300,000 |
| | 2014 | 2014 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R41AI104034 | Modulation of the Innate Immune System by Fisetin for the Treatment of AD | 000 | 2 | NIH | 6/12/2014 | $299,968 |
|
| Issue Date FY: 2013 ( Subtotal = $599,968 ) |
| | 2013 | 2013 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R41AI104034 | Modulation of the Innate Immune System by Fisetin for the Treatment of AD | 000 | 1 | NIH | 8/1/2013 | $299,968 |
| | 2013 | 2013 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R43AI100398 | siRNA Modulation of the Immune Response | 000 | 1 | NIH | 12/27/2012 | $300,000 |
|
| Issue Date FY: 2012 ( Subtotal = $699,475 ) |
| | 2012 | 2012 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R44HL081976 | FIV VECTORS FOR THE TREATMENT OF HEMOPHILIA A | 000 | 4 | NIH | 8/6/2012 | $699,475 |
|
| Issue Date FY: 2011 ( Subtotal = $1,184,311 ) |
| | 2011 | 2011 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R44HL081976 | FIV VECTORS FOR THE TREATMENT OF HEMOPHILIA A | 002 | 3 | NIH | 5/26/2011 | $1,009,436 |
| | 2011 | 2011 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R44HL081976 | FIV VECTORS FOR THE TREATMENT OF HEMOPHILIA A | 000 | 2 | NIH | 3/30/2011 | $54,720 |
| | 2011 | 2010 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R44HL081976 | FIV VECTORS FOR THE TREATMENT OF HEMOPHILIA A | 001 | 2 | NIH | 5/23/2011 | $120,155 |
|
| Issue Date FY: 2010 ( Subtotal = $785,649 ) |
| | 2010 | 2010 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R44HL081976 | FIV VECTORS FOR THE TREATMENT OF HEMOPHILIA A | 000 | 2 | NIH | 5/28/2010 | $785,649 |
|
| Issue Date FY: 2009 ( Subtotal = $299,657 ) |
| | 2009 | 2009 | VIROGENICS INC | P.O. BOX 2702 | DEL MAR | CA | 92014-5702 | SAN DIEGO | USA | R43AI080434 | A NOVEL IMMUNE MODULATOR/ ADJUVANT FOR HIV VACCINES | 000 | 2 | NIH | 6/23/2009 | $299,657 |
|
| Issue Date FY: 2008 ( Subtotal = $299,657 ) |
| | 2008 | 2008 | VIROGENICS INC | PO BOX 2702 | DEL MAR | CA | 92014 | SAN DIEGO | USA | R43AI080434 | A NOVEL IMMUNE MODULATOR/ ADJUVANT FOR HIV VACCINES | 000 | 1 | NIH | 7/7/2008 | $299,657 |
|
|
